dihydroxyphenylalanine has been researched along with Schizotypal Personality Disorder in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Schizotypal Personality Disorder: A personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howes, OD | 1 |
Montgomery, AJ | 1 |
Asselin, MC | 1 |
Murray, RM | 1 |
Valli, I | 1 |
Tabraham, P | 1 |
Bramon-Bosch, E | 1 |
Valmaggia, L | 1 |
Johns, L | 1 |
Broome, M | 1 |
McGuire, PK | 1 |
Grasby, PM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis[NCT05282277] | Phase 4 | 103 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for dihydroxyphenylalanine and Schizotypal Personality Disorder
Article | Year |
---|---|
Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Topics: Adult; Brain Mapping; Cognition Disorders; Corpus Striatum; Diagnostic and Statistical Manual of Men | 2009 |